# Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis

> **NCT05247866** · PHASE4 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 21 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DIETARY_SUPPLEMENT:** Eosinophilic Esophagitis (EoE) food introduction-1st
- **DIETARY_SUPPLEMENT:** Eosinophilic Esophagitis (E0E) food introduction-2nd
- **DIETARY_SUPPLEMENT:** Eosinophilic Esophagitis (EoE) Food introduction-3rd dose
- **DRUG:** Dupilumab

## Key facts

- **NCT ID:** NCT05247866
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-16
- **Primary completion:** 2025-01-21
- **Final completion:** 2025-01-21
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05247866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05247866, "Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05247866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*